Earnings Feed
Start Free
HALOZYME THERAPEUTICS, INC.·4

Feb 24, 6:12 PM ET

Torley Helen 4

4 · HALOZYME THERAPEUTICS, INC. · Filed Feb 24, 2026

Insider Transaction Report

Form 4
Period: 2026-02-20
HALOZYME THERAPEUTICS, INC.HALO
Torley Helen
DirectorPRESIDENT AND CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-20+16,757→ 766,488 total
  • Tax Payment

    Common Stock

    [F1]
    2026-02-20$70.98/sh−9,040$641,659→ 757,448 total
  • Exercise/Conversion

    Common Stock

    2026-02-23+22,436→ 779,884 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-23$70.64/sh−12,104$855,027→ 767,780 total
  • Exercise/Conversion

    Restricted Stock Units

    [F3]
    2026-02-20−16,757→ 50,270 total
    Exercise: $0.00→ Common Stock (16,757 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F3]
    2026-02-23−22,436→ 44,872 total
    Exercise: $0.00→ Common Stock (22,436 underlying)
Footnotes (3)
  • [F1]The reported disposition of 9,040 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
  • [F2]The reported disposition of 12,104 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
  • [F3]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
Signature
/s/ James R. Oehler, Attorney-in-Fact|2026-02-24

Documents

1 file
  • 4
    wk-form4_1771974762.xmlPrimary

    FORM 4